Biblio

Export 1914 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
P. J. Lao, Handen, B. L., Betthauser, T. J., Mihaila, I., Hartley, S. L., Cohen, A. D., Tudorascu, D. L., Bulova, P. D., Lopresti, B. J., Tumuluru, R. V., Murali, D., Mathis, C. A., Barnhart, T. E., Stone, C. K., Price, J. C., Devenny, D. A., Johnson, S. C., Klunk, W. E., and Christian, B. T., “Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 2, pp. 631-644, 2018.
P. J. Lao, Handen, B. L., Betthauser, T. J., Mihaila, I., Hartley, S. L., Cohen, A. D., Tudorascu, D. L., Bulova, P. D., Lopresti, B. J., Tumuluru, R. V., Murali, D., Mathis, C. A., Barnhart, T. E., Stone, C. K., Price, J. C., Devenny, D. A., Johnson, S. C., Klunk, W. E., and Christian, B. T., “Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 2, pp. 631-644, 2018.
M. L. Gosztyla, Brothers, H. M., and Robinson, S. R., “Alzheimer's Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1495-1506, 2018.
R. N. Martins, Villemagne, V., Sohrabi, H. R., Chatterjee, P., Shah, T. M., Verdile, G., Fraser, P., Taddei, K., Gupta, V. B., Rainey-Smith, S. R., Hone, E., Pedrini, S., Lim, W. Ling, Martins, I., Frost, S., Gupta, S., O'Bryant, S., Rembach, A., Ames, D., Ellis, K., Fuller, S. J., Brown, B., Gardener, S. L., Fernando, B., Bharadwaj, P., Burnham, S., Laws, S. M., Barron, A. M., Goozee, K., Wahjoepramono, E. J., Asih, P. R., Doecke, J. D., Salvado, O., Bush, A. I., Rowe, C. C., Gandy, S. E., and Masters, C. L., “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
R. N. Martins, Villemagne, V., Sohrabi, H. R., Chatterjee, P., Shah, T. M., Verdile, G., Fraser, P., Taddei, K., Gupta, V. B., Rainey-Smith, S. R., Hone, E., Pedrini, S., Lim, W. Ling, Martins, I., Frost, S., Gupta, S., O'Bryant, S., Rembach, A., Ames, D., Ellis, K., Fuller, S. J., Brown, B., Gardener, S. L., Fernando, B., Bharadwaj, P., Burnham, S., Laws, S. M., Barron, A. M., Goozee, K., Wahjoepramono, E. J., Asih, P. R., Doecke, J. D., Salvado, O., Bush, A. I., Rowe, C. C., Gandy, S. E., and Masters, C. L., “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
R. N. Martins, Villemagne, V., Sohrabi, H. R., Chatterjee, P., Shah, T. M., Verdile, G., Fraser, P., Taddei, K., Gupta, V. B., Rainey-Smith, S. R., Hone, E., Pedrini, S., Lim, W. Ling, Martins, I., Frost, S., Gupta, S., O'Bryant, S., Rembach, A., Ames, D., Ellis, K., Fuller, S. J., Brown, B., Gardener, S. L., Fernando, B., Bharadwaj, P., Burnham, S., Laws, S. M., Barron, A. M., Goozee, K., Wahjoepramono, E. J., Asih, P. R., Doecke, J. D., Salvado, O., Bush, A. I., Rowe, C. C., Gandy, S. E., and Masters, C. L., “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
R. N. Martins, Villemagne, V., Sohrabi, H. R., Chatterjee, P., Shah, T. M., Verdile, G., Fraser, P., Taddei, K., Gupta, V. B., Rainey-Smith, S. R., Hone, E., Pedrini, S., Lim, W. Ling, Martins, I., Frost, S., Gupta, S., O'Bryant, S., Rembach, A., Ames, D., Ellis, K., Fuller, S. J., Brown, B., Gardener, S. L., Fernando, B., Bharadwaj, P., Burnham, S., Laws, S. M., Barron, A. M., Goozee, K., Wahjoepramono, E. J., Asih, P. R., Doecke, J. D., Salvado, O., Bush, A. I., Rowe, C. C., Gandy, S. E., and Masters, C. L., “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
R. N. Martins, Villemagne, V., Sohrabi, H. R., Chatterjee, P., Shah, T. M., Verdile, G., Fraser, P., Taddei, K., Gupta, V. B., Rainey-Smith, S. R., Hone, E., Pedrini, S., Lim, W. Ling, Martins, I., Frost, S., Gupta, S., O'Bryant, S., Rembach, A., Ames, D., Ellis, K., Fuller, S. J., Brown, B., Gardener, S. L., Fernando, B., Bharadwaj, P., Burnham, S., Laws, S. M., Barron, A. M., Goozee, K., Wahjoepramono, E. J., Asih, P. R., Doecke, J. D., Salvado, O., Bush, A. I., Rowe, C. C., Gandy, S. E., and Masters, C. L., “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
M. F. Bassendine, Taylor-Robinson, S. D., Fertleman, M., Khan, M., and Neely, D., “Is Alzheimer's Disease a Liver Disease of the Brain?”, J Alzheimers Dis, vol. 75, no. 1, pp. 1-14, 2020.
M. Piton, Hirtz, C., Desmetz, C., Milhau, J., Lajoix, A. Dominique, Bennys, K., Lehmann, S., and Gabelle, A., “Alzheimer's Disease: Advances in Drug Development.”, J Alzheimers Dis, vol. 65, no. 1, pp. 3-13, 2018.
C. Trieu, Van Harten, A. C., Leeuwis, A. E., Exalto, L. G., Hooghiemstra, A. M., Verberk, I. M. W., Allaart, C. P., La Rocca, H. - P. Brunner-, L Kappelle, J., van Oostenbrugge, R. J., Biessels, G. - J., Teunissen, C. E., and van der Flier, W. M., “Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis.”, J Alzheimers Dis, vol. 98, no. 3, pp. 987-1000, 2024.
C. Milano, Hoxhaj, D., Del Chicca, M., Pascazio, A., Paoli, D., Tommasini, L., Vergallo, A., Pizzanelli, C., Tognoni, G., Nuti, A., Ceravolo, R., Siciliano, G., Hampel, H., and Baldacci, F., “Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers.”, J Alzheimers Dis, vol. 94, no. 2, pp. 611-625, 2023.
E. R. Blonz, “Alzheimer's Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1223-1229, 2017.
J. Dumurgier, Hanseeuw, B. J., Hatling, F. B., Judge, K. A., Schultz, A. P., Chhatwal, J. P., Blacker, D., Sperling, R. A., Johnson, K. A., Hyman, B. T., and Gómez-Isla, T., “Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1451-1459, 2017.
U. Rüb, Stratmann, K., Heinsen, H., Seidel, K., Bouzrou, M., and Korf, H. - W., “Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.”, J Alzheimers Dis, vol. 57, no. 3, pp. 683-696, 2017.
A. Watad, Bragazzi, N. L., Tiosano, S., Yavne, Y., Comaneshter, D., Cohen, A. D., and Amital, H., “Alzheimer's Disease in Systemic Sclerosis Patients: A Nationwide Population-Based Cohort Study.”, J Alzheimers Dis, vol. 65, no. 1, pp. 117-124, 2018.
R. C. Petersen, Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., and Weiner, M. W., “Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.”, Neurology, vol. 74, no. 3, pp. 201-9, 2010.
G. Forloni and Balducci, C., “Alzheimer's Disease, Oligomers, and Inflammation.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1261-1276, 2018.
A. S. Buchman, Leurgans, S. E., Kim, N., Agrawal, S., Oveisgharan, S., Zammit, A. R., VanderHorst, V., Nag, S., and Bennett, D. A., “Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia.”, J Alzheimers Dis, vol. 96, no. 2, pp. 563-578, 2023.
A. S. Buchman, Leurgans, S. E., Kim, N., Agrawal, S., Oveisgharan, S., Zammit, A. R., VanderHorst, V., Nag, S., and Bennett, D. A., “Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia.”, J Alzheimers Dis, vol. 96, no. 2, pp. 563-578, 2023.
C. Ferrari, Lombardi, G., Polito, C., Lucidi, G., Bagnoli, S., Piaceri, I., Nacmias, B., Berti, V., Rizzuto, D., Fratiglioni, L., and Sorbi, S., “Alzheimer's Disease Progression: Factors Influencing Cognitive Decline.”, J Alzheimers Dis, vol. 61, no. 2, pp. 785-791, 2018.
C. Ferrari, Lombardi, G., Polito, C., Lucidi, G., Bagnoli, S., Piaceri, I., Nacmias, B., Berti, V., Rizzuto, D., Fratiglioni, L., and Sorbi, S., “Alzheimer's Disease Progression: Factors Influencing Cognitive Decline.”, J Alzheimers Dis, vol. 61, no. 2, pp. 785-791, 2018.
G. Liu, Zhang, Y., Wang, L., Xu, J., Chen, X., Bao, Y., Hu, Y., Jin, S., Tian, R., Bai, W., Zhou, W., Wang, T., Han, Z., Zong, J., and Jiang, Q., “Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
G. Liu, Zhang, Y., Wang, L., Xu, J., Chen, X., Bao, Y., Hu, Y., Jin, S., Tian, R., Bai, W., Zhou, W., Wang, T., Han, Z., Zong, J., and Jiang, Q., “Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
C. Babiloni, Noce, G., Di Bonaventura, C., Lizio, R., Eldellaa, A., Tucci, F., Salamone, E. M., Ferri, R., Soricelli, A., Nobili, F., Famá, F., Arnaldi, D., Palma, E., Cifelli, P., Marizzoni, M., Stocchi, F., Bruno, G., Di Gennaro, G., Frisoni, G. B., and Del Percio, C., “Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 903-931, 2022.

Pages